|
Clazakizumab Clinical Trials
1 actively recruiting trial across 1 location
Also known as: LY5724886
Pipeline
Phase 2: 1
Top Sponsors
- Eli Lilly and Company1
Indications
- Renal Insufficiency, Chronic1
- Cardiovascular Disease1
- Hypertension1
- Diabetes1
- Atherosclerosis1
Huntsville, Alabama1 trial
A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
Heart Center Research, LLC
Phase 2
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.